177Lu-DOTATATE and177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

177Lu-DOTATATE and177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment

Published:2019 Issue:4 Volume:18 Page:406
ISSN:1450-1147
Container-title:World Journal of Nuclear Medicine
language:en
Short-container-title:World J Nucl Med

Author:

Assadi Majid,Ahmadzadehfar Hojjat

Publisher

Medknow

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of the First 40 Cases of¹⁷⁷Lu-PSMA Therapy in the Treatment of Non-prostatic Cancer;Anticancer Research;2024-05-31

2. Current clinical application of lutetium‑177 in solid tumors (Review);Experimental and Therapeutic Medicine;2024-03-26

3. Peptide-based strategies for overcoming multidrug-resistance in cancer therapy;Chinese Chemical Letters;2024-03

4. Modern Diagnostic and Therapeutic Approaches in Thyroid Diseases: Theranostics and the Changing Role of Radioactive Isotopes;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

5. PSMA-targeted therapy for non-prostate cancers;Frontiers in Oncology;2023-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP